This seminar deals with current strategies of formulation development. Here case studies
for therapeutic agents from different leading companies will show that there is no perfect
recipe for an optimal formulation.
The last step of drug manufacturing represents most difficult one. Especially in terms of
recombinant proteins for therapeutic application formulation drastically depends on
way of application (liquid or solid formulation). Here several physical properties of the
therapeutic agent must be considered. Lyophilisation represents a popular formulation
technique, but also requires highest investments in biological productions.
Prospective project managers dealing with fill and finish have to pay regard to individual
properties of the agent before setting up an optimal formulation strategy. A long-term
and easy-to-apply dosage form increases attractiveness of biotech products for therapy
application.
This seminar deals with current strategies of formulation development. Here case studies
for therapeutic agents from different leading companies will show that there is no perfect
recipe for an optimal formulation.
